Roche: results from two multi-site collaborative studies highlight the value of 454 sequencing systems for genotyping applications

PENZBERG, Germany -- 454 Life Sciences, a Roche Company (SIX: RO, ROG; OTCQX: RHHBY), has announced promising new results from a multi-site collaborative research study which used the company's Genome...

read more

 

Please choose:

 RSS Feed | more news

International News